INTERVENTIONAL AND STRUCTURAL CARDIOLOGIST BROADENS HOBART’S SURGICAL ABILITIES Tasmanian born, bred and educated cardiologist
With
Dr Heath Adams,
Interventional and Structural Cardiologist
Director of Structural Intervention, Royal Hobart Hospital &
Visiting Medical Officer (VMO) Cardiologist
Hobart Private Hospital &
Adjunct Senior Researcher
Menzies Institute for Medical Research,
University of Tasmania
PEOPLE IN HEATH CARE | AUSTRALIAN HEATH JOURNAL SEGMENT
Filmed in Hobart | March 2025
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
Dr Adams achieved First Class Honours in MBBS at UTAS in 2009. He achieved a Fellowship of the Royal College of Physicians in Adult Cardiology in 2016 after training appointments in Victoria. In 2019, he was the structural heart fellow at St Thomas’ Hospital, London, a worldwide centre of excellence in TAVI and structural heart procedures. This fellowship was supported by the prestigious Dr MG Ciezar Memorial Scholarship in cardiovascular medicine from the University of Tasmania.
Dr Adams has published over 50 manuscripts and abstracts in peer-reviewed journals and has been involved in authoring educational book chapters on TAVI. His current research involves streamlined TAVI, assessing frailty outcomes post valve intervention and performing large-scale real-world outcomes with new structural heart interventions. Dr Adams is a clinical supervisor for trainee physicians at the Royal Hobart Hospital, is a member of the CSANZ Interventional Council.
Heath is passionate about clinical innovation, research and patient outcomes. In his free time, Heath enjoys bushwalking, running, cycling and trying to better his golf game whilst being a busy father to 3 children under the age of 6.
Source: supplied and supplemented
-
State of private healthcare in Australia
Australia’s healthcare system is often described as a mixed system, with a combination of public and private providers. While public healthcare through Medicare provides universal coverage for essential services, private healthcare offers additional options and amenities for those who can afford them.
Private Healthcare Australia (PHA) is the Australian private health insurance industry’s peak representative body that currently has 21registered health funds throughout Australia and collectively represents 98% of people covered by private health insurance. PHA member funds today provide healthcare benefits for over 14 million Australians.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
-
A clinical research career working Sponsor-side, CRO-side to Site-side
In July 2025, Paratus Clinical, a Australian provider of dedicated clinical trial services, announced the appointment of Megan Morrison as its new Chief Executive Officer, at the same time as a significant milestone as the company celebrating over a decade of impact in the clinical research space. Paratus now operates a network of five purpose-built, research-only clinics along Australia’s eastern seaboard.
